News Sentiment

SRRK sentiment intelligence

Scholar Rock Holding Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 52.86 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-6.8% over one week, +11.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -6.8% Price reacting lower
Trend fit Trend active 11.7% over four weeks
Fair value 89.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 37
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 8
simplywall.st 6
TradingView 6
Investing.com 4
Business Wire 3
Quartr 3
MarketBeat 3

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 21
Analyst action 3
Regulatory and legal 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
TradingView Direct company coverage

2QK Forecast — Price Target — Prediction for 2027

This article provides a forecast for Scholar Rock Holding Corp. (2QK) stock, including analyst price targets, ratings, and financial performance. It covers historical stock prices, upcoming earnings dates, recent financial results, and details about the company's revenue, net inc

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 00:41
Source
TradingView
Investing.com Direct company coverage

Scholar Rock Holding Corp stock hits 52-week high at 52.21 USD

Scholar Rock Holding Corp (SRRK) has reached a new 52-week high of $52.19, with shares trading around $52.11, marking a 53.5% surge over the past year. This achievement is backed by analyst optimism, with four analysts revising earnings estimates upward, despite its InvestingPro

Tone
Positive 66/100
Event
Earnings
Published
24 Jun 2026 15:11
Source
Investing.com
AD HOC NEWS Direct company coverage

Scholar Rock Holding eyes key EMA decision, shares trade higher on NASDAQ

Scholar Rock Holding is nearing a key EMA review decision for its lead SMA therapy, apitegromab, which is scheduled for June 30, 2026. This comes ahead of a US FDA PDUFA date on September 30, 2026, after a recent resubmission of its biologics license application. The company's sh

Tone
Positive 74/100
Event
Market update
Published
23 Jun 2026 15:09
Source
AD HOC NEWS
Sahm Direct company coverage

Scholar Rock Holding (SRRK) Is Up 7.1% After Apitegromab BLA Resubmission And Dual Supply Strategy - Has The Bull Case Changed?

Scholar Rock Holding (SRRK) recently resubmitted its biologics license application for apitegromab, which now includes two fill-finish facilities and has a PDUFA date of September 30, 2026. This dual supply strategy aims to reduce operational risk for the spinal muscular atrophy

Tone
Positive 67/100
Event
Macro sensitivity
Published
22 Jun 2026 15:40
Source
Sahm
Stock Titan Direct company coverage

Scholar Rock brings new apitegromab data to two rare muscle-disease meetings

Scholar Rock (NASDAQ: SRRK) announced it will present new clinical data and research updates related to its neuromuscular portfolio, including the Phase 3 SAPPHIRE and Phase 2 FORGE studies, at two upcoming meetings. The data will be shared at the 2026 Annual Cure SMA Research an

Tone
Positive 73/100
Event
Market update
Published
22 Jun 2026 12:12
Source
Stock Titan
TradingKey Direct company coverage

Scholar Rock Holding Corp (SRRK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Scholar Rock Holding Corp (SRRK), detailing its current earnings forecast score, analyst ratings, and price targets. It highlights that the company's stock has an average price target of $47.50, with a majority of analysts recommendi

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 13:39
Source
TradingKey